Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

RGC

Regencell Bioscience Holdings Ltd

Apr 18 • 04:00PM ET

5.22

Dollar change +0.48
Percentage change 10.18	%

Healthcare • Drug Manufacturers - Specialty & Generic • Hong Kong • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	7.60%	Shs Outstand	13.01M	Perf Week	42.23%
Market Cap	67.91M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	12.02M	Perf Month	12.86%
Income	-5.87M	PEG	-	EPS next Q	-	Inst Own	0.13%	Short Float	0.03%	Perf Quarter	-50.28%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.87	Perf Half Y	-66.96%
Book/sh	0.92	P/B	5.65	EPS next Y	-	ROA	-38.32%	Short Interest	0.00M	Perf Year	-82.01%
Cash/sh	0.89	P/C	5.87	EPS next 5Y	-	ROE	-40.36%	52W Range	3.16 - 31.30	Perf YTD	-50.29%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-95.48%	ROI	-48.70%	52W High	-83.32%	Beta	-0.34
Dividend TTM	-	Quick Ratio	19.15	Sales past 5Y	0.00%	Gross Margin	-	52W Low	65.19%	ATR (14)	0.67
Dividend Ex-Date	Feb 15, 2018	Current Ratio	19.15	EPS Y/Y TTM	22.82%	Oper. Margin	0.00%	RSI (14)	56.88	Volatility	21.44% 15.84%
Employees	12	Debt/Eq	0.04	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	32.80%	Payout	-	Rel Volume	2.48	Prev Close	4.74
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	4.51K	Price	5.22
SMA20	34.01%	SMA50	-11.07%	SMA200	-67.47%	Trades		Volume	11,203	Change	10.18%

Nov-15-23 04:31PM	15 Developed Countries with Lowest Autism Rates (Insider Monkey) +11.11%
Jul-31-23 08:15AM	With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.)
Apr-03-23 07:25AM	One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year (Simply Wall St.)
Feb-21-23 06:36AM	With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.) -5.99%
Nov-21-22 06:49AM	Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth (Simply Wall St.)
07:55AM	Loading…
Nov-15-22 07:55AM	RGC: Forging a New Approach to ADHD and ASD (Zacks Small Cap Research)
Oct-25-22 06:55AM	One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year (Simply Wall St.)
Sep-14-22 06:55AM	81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently (Simply Wall St.)
Sep-12-22 09:15AM	Regencell Biosciences Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial (Business Wire)
Jun-20-22 05:27AM	RGC: CEO Figuratively Putting His Money Where His Mouth Is (Zacks Small Cap Research)
May-24-22 05:46AM	RGC: Second investigational study of RGC-COV19 replicates results of earlier trial in eliminating COVID-19 symptoms. (Zacks Small Cap Research)
May-18-22 08:05AM	Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period (Business Wire)
06:14AM	The Founder of Regencell Bioscience Holdings Limited (NASDAQ:RGC), Yat-Gai Au, Just Bought A Few More Shares (Simply Wall St.)
May-16-22 08:56AM	Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO (Business Wire)
Apr-14-22 10:03AM	RGC: Regencell Bioscience - Investigational Liquid-Formula RGC-COV19 Shows Promise in Eliminating COVID-19 Symptoms (Zacks Small Cap Research)
06:09AM	Loading…
Apr-07-22 06:09AM	What Is The Ownership Structure Like For Regencell Bioscience Holdings Limited (NASDAQ:RGC)? (Simply Wall St.) +9.34%
Mar-01-22 08:30AM	Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network (ACCESSWIRE)
Feb-17-22 11:40AM	Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms (Benzinga) +14.45%
Feb-16-22 08:42PM	Regencell Biosciences Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial (Business Wire)
Dec-13-21 08:35AM	Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors (Business Wire)
Nov-22-21 08:15AM	Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO (Business Wire)
08:00AM	Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index (Business Wire)
Nov-02-21 04:00AM	RGC: Traditional Chinese Medicine Approach for treatment of neurodevelopmental conditions (Zacks Small Cap Research)
Oct-19-21 11:44AM	Do Institutions Own Regencell Bioscience Holdings Limited (NASDAQ:RGC) Shares? (Simply Wall St.)
Sep-10-21 06:18AM	Cineworld to pay £122m to dissenting shareholders after Regal takeover (The Independent)
02:42AM	UPDATE 1-Cineworld pays $170 mln to Regal investors unhappy with 2017 buyout (Reuters)
Sep-02-21 08:00AM	Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment (Business Wire)
Aug-20-21 08:00AM	Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriters Over-Allotment Option (Business Wire) +204.13%
Aug-05-21 08:00AM	Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders (Business Wire) +6.29%
Jul-20-21 04:05PM	Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering (Business Wire)
11:43AM	Loading…
Jul-16-21 11:43AM	Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering (Business Wire)

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RGC

Regencell Bioscience Holdings Ltd

Upgrade your FINVIZ experience